Literature DB >> 8737162

Fluconazole plus allopurinol in treatment of visceral leishmaniasis.

D Torrús, V Boix, B Massa, J Portilla, M Pérez-Mateo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8737162     DOI： 10.1093/jac/37.5.1042

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  7 in total

1.  Antileishmanial efficacy of fluconazole and miltefosine in combination with an immunomodulator--picroliv.

Authors:  Nishi Shakya; Shraddha A Sane; Suman Gupta
Journal:  Parasitol Res       Date:  2011-01-07       Impact factor: 2.289

2.  Experimental evaluation of second-line oral treatments of visceral leishmaniasis caused by Leishmania infantum.

Authors:  J P Gangneux; M Dullin; A Sulahian; Y J Garin; F Derouin
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

3.  Therapeutic switching in leishmania chemotherapy: a distinct approach towards unsatisfied treatment needs.

Authors:  Nishi Shakya; Preeti Bajpai; Suman Gupta
Journal:  J Parasit Dis       Date:  2011-05-20

Review 4.  Therapeutic options for visceral leishmaniasis.

Authors:  Begoña Monge-Maillo; Rogelio López-Vélez
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

Review 5.  Visceral leishmaniasis and HIV coinfection in the Mediterranean region.

Authors:  Begoña Monge-Maillo; Francesca F Norman; Israel Cruz; Jorge Alvar; Rogelio López-Vélez
Journal:  PLoS Negl Trop Dis       Date:  2014-08-21

6.  Atypical presentation of cutaneous leishmaniasis in a renal transplant recipient successfully treated with allopurinol and fluconazole.

Authors:  Soumaya Yaich; Khaled Charfeddine; Abderrahmen Masmoudi; Mondher Masmoudi; Sawssen Zaghdhane; Hamida Turki; Jamil Hachicha
Journal:  Ann Saudi Med       Date:  2012-07-01       Impact factor: 1.526

Review 7.  A screen-and-treat strategy targeting visceral leishmaniasis in HIV-infected individuals in endemic East African countries: the way forward?

Authors:  Johan van Griensven; Ermias Diro; Rogelio Lopez-Velez; Koert Ritmeijer; Marleen Boelaert; Ed E Zijlstra; Asrat Hailu; Lutgarde Lynen
Journal:  PLoS Negl Trop Dis       Date:  2014-08-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.